Evidence map›Paper›PMID 34538522›Full record

ArticleVaccine2021

Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.

Sara Suliman, Puck T Pelzer, Moagi Shaku, Virginie Rozot, Simon C Mendelsohn

Abstract readConference Proceedings
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Challenges in developing new tuberculosis vaccines.Memorias do Instituto Oswaldo Cruz · 2025
    Review
  2. Article
  3. Review
  4. Oridonin InhibitsPathogens (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara SulimanStop TB Partnership Working Group on New TB Vaccines, New York, NY, USA; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Puck T PelzerStop TB Partnership Working Group on New TB Vaccines, New York, NY, USA; KNCV Tuberculosis Foundation, The Hague, the Netherlands.
Moagi ShakuStop TB Partnership Working Group on New TB Vaccines, New York, NY, USA.
Virginie RozotStop TB Partnership Working Group on New TB Vaccines, New York, NY, USA; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, Wernher and Beit South Building, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.
Simon C MendelsohnStop TB Partnership Working Group on New TB Vaccines, New York, NY, USA; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, Wernher and Beit South Building, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. Electronic address: simon.mendelsohn@uct.ac.za.

Funding

HIV-associated Tuberculosis Training Program (HATTP)D43TW010559 · FIC · UNIVERSITY OF CAPE TOWN · PI Graeme Ayton Meintjes · 2017 to 2026
$3.0M
6th Global Forum on TB VaccinesR13AI157206 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI FREVOL, AUDE · 2021 to 2021
$7k
FIC NIH HHS D43 TW010559NIAID NIH HHS R13 AI157206
6 · The paper itself

Abstract

The Global Forum on Tuberculosis (TB) Vaccines was held virtually from 20 to 22 April 2021, marking its 20

Indexed as

COVID-19TuberculosisTuberculosis VaccinesHumansPandemicsSARS-CoV-2Tuberculosis VaccinesBCGCOVID-19FundingPandemicPipelineTuberculosisVaccine

Identifiers

PMID34538522
PMCPMC8441545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.